secwatch.observer — SEC 8-K summary
======================================

Issuer:     Thermon Group Holdings, Inc. (THR)
CIK:        0001489096
Form:       8-K
Filed at:   2022-09-06T23:59:59+00:00
Accession:  0001489096-22-000127
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Thermon appoints Dr. Angela Strzelecki to board of directors
------------------------------------------------------------

- Appointed Dr. Angela Strzelecki as director effective September 6, 2022; board size increased from 7 to 8.
- She currently serves as President of Pharmaceutical Solutions at IFF (NYSE:IFF) and previously held global roles at DuPont.
- She will serve on the Finance, Human Capital Management and Compensation, and Nominating and Corporate Governance Committees.
- Received a pro-rated annual grant of ~$6,454 in common stock under the 2020 Long-Term Incentive Plan.
- Board determined she is independent under NYSE standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1489096/000148909622000127/0001489096-22-000127-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1489096/000148909622000127/thr-20220906.htm
  HTML page:      https://secwatch.observer/filing/0001489096-22-000127

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer